Journal Article

Combination Therapy With Vigabatrin and Prednisolone Versus Vigabatrin Alone for Infantile Spasms

Boonkrongsak, Rachata, Wittawassamrankul, Raviwan, Trongkamolchai, Kantapon, Suwannachote, Sirorat, Sri‐Udomkajorn, Somjit, Sakpichaisakul, Kullasate, Arya, Ravindra

2025

Overview

Objective The study evaluated the effectiveness of combination therapy with vigabatrin and prednisolone versus vigabatrin alone for treating infantile epileptic spasms syndrome (IESS). Methods This single‐center, single‐blind, randomized trial enrolled infants aged 2–14 months with new‐onset IESS, randomly assigned them (1:1) to receive either combination therapy with vigabatrin (100–150 mg/kg/day) and prednisolone (40–60 mg/day) or vigabatrin alone. The primary outcome was sustained spasm remission between days 14 and 42. The trial (ClinicalTrials.gov identifier) was terminated early due to an interim analysis revealing a significant difference between treatment groups. Results In all, 17 infants were assigned to combination therapy and 24 to vigabatrin alone. The median lead time to treatment for combination therapy was 30 days, compared to 60 days for the vigabatrin group (p = 0.442). Sustained spasm remission between days 14 and 42 occurred in 13 (77%) of 17 infants on combination therapy and in 8 (33%) of 24 infants on vigabatrin alone (OR 6.5, 95% CI 1.7, 29.6, p = 0.009). Combination therapy was more effective in achieving an electroclinical response by day 14 (OR 9.3, 95% CI 2.0, 54.3, p = 0.006) but not by day 42 (OR 1.9, 95% CI 0.5, 7.1, p = 0.351). Hospitalization occurred in six (35%) infants in the combination therapy group and two (8%) in the vigabatrin alone group (p = 0.05). One death was reported in the vigabatrin group. Interpretation Despite early termination, this study showed that combination therapy is significantly more effective in achieving clinical remission of spasms and an electroclinical response by day 14. Trial Registration NCT04302116

• Publisher: John Wiley & Sons, Inc,John Wiley and Sons Inc,Wiley
• Subject: Anticonvulsants - administration & dosage / Anticonvulsants - pharmacology / Combination therapy / Convulsions & seizures / Drug Therapy, Combination / Electroencephalography / Epilepsy / Female / Humans / Hypotheses / Infant / infantile epileptic spasms syndrome / infantile spasms / Investigations / Male / Pediatrics / Prednisolone - administration & dosage / Prednisolone - pharmacology / Single-Blind Method / Spasms, Infantile - drug therapy / Treatment Outcome / vigabatrin / Vigabatrin - administration & dosage / Vigabatrin - pharmacology / west syndrome